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known previous diagnosis or current prescription for these diseases.
The angiographic data included the number of arteries with signiﬁcant
disease and the degree of stenosis. Signiﬁcant CAD was deﬁned as
≥70% luminal diameter narrowing in at least one coronary artery
(N50% for the proximal left anterior descending artery). Severe CAD
was deﬁned as the presence of signiﬁcant CAD of proximal left anterior
descending artery, three-vessel CAD or two-vessel CAD involving the
left anterior descending artery [5].
Stata version 11.1 for Windows (StataCorp LP, College Station, TX)
was used for statistical analysis. Continuous variables are expressed as
mean ± standard deviation, except those without normal distribution,Coronary artery disease (CAD) accounts for about two-thirds of
cases of heart failure with reduced ejection fraction (HFrEF) [1]. Angina
symptoms and cardiovascular risk factors (CVRF) are not sufﬁcient to
establish an ischemic etiology and according to recommendations coro-
nary angiography (CA) is the gold standard [1–3]. There is a paucity of
information on the performance of CA for detecting CAD in HFrEF with-
out known CAD [4]. We aimed to determine the frequency of CAD in
HFrEF patients of unknown etiology and without known CAD, and to
identify variables associated with the presence and severity of CAD.
We retrospectively identiﬁed patients from a HF clinic, submitted to
CA until the end of 2013. Exclusion criteria were HFwith left ventricular
ejection fraction N50%, other etiologies for HF, angina, known CAD
(previous myocardial infarction (MI), coronary revascularization) and
indication for CA for other purposes. The study protocol conforms to
the ethical guidelines of the declaration of Helsinki and was approved
by the local ethics committee. Data were abstracted from the clinical
records, including demographic variables, HF characteristics, routine
laboratory values, CVRF: history of smoking, body mass index, hyper-
tension, dyslipidemia, diabetesmellitus (DM) and family history of pre-
mature MI; and comorbidities: atrial ﬁbrillation and chronic kidney, Centro Hospitalar de São João,
ortugal.
.
.disease. Dyslipidemia, hypertension and DM were deﬁned as either a
expressed as median (interquartile range). The qualitative variables
are expressed as absolute frequencies and percentages. Comparison of
above-mentioned variables in both groups (with or without CAD) was
performed by using t-test and the Mann–Whitney test for continuous
variables with skewed distribution, and the chi-square test for categor-
ical variables. For all analyses, p b 0.05 was considered statistically
signiﬁcant.
We included 168 patients with HFrEFwho fulﬁlled the inclusion and
exclusion criteria. Baseline characteristics are summarized in Table 1. Of
these, 70% had no CAD, 31% had signiﬁcant CAD, among whom 23.1%
had severe CAD. Patients with CAD were older, more frequently male
and had a higher prevalence (despite non-signiﬁcantly) of several CVRF.
The diagnostic yield of CA, in women and men, according to the
history of risk factors is summarized in Table 2. Signiﬁcant CAD was
more than twice as prevalent in the presence than in the absence of
risk factors. The presence of signiﬁcant CAD in the latter group was
14.3% in men and 12.5% in women.
Our results show that CAD is the etiology of HFrEF in a third of
patientswithout angina and noprevious coronary event. Even in the ab-
sence of CVRF, more than 10% of both men and women had signiﬁcant
CAD. These results, although involving a young population, support
the routine performance of CA in HFrEF independently of CAD risk fac-
tors. CAD is the most frequent HFrEF etiology, although the prevalence
varies markedly according to populations [1,6]. The determination of
ischemic etiology in HF patients is of major signiﬁcance since it can dic-
tate treatment options and ischemic HF is independently associated
with a worse long-term outcome [7,8]. In patients with angina or MI,
Table 1
Patient characteristics.
Signiﬁcant CAD Severe CAD
All No Yes p-Value No Yes p-Value
No. of patients 168 112 56 129 39
Age (years), mean (SD) 59.7 (11.8) 57.7 (11.6) 63.7 (11.3) 0.002 58.3 (11.5) 64.5 (11.8) 0.004
Male sex, n (%) 119 (70.8) 75 (67.0) 44 (78.6) 0.119 89 (69.0) 30 (76.9) 0.340
LVEF (%), mean (SD) 27.0 (9.8) 26.1 (10.3) 28.5 (8.8) 0.232 26.6 (10.0) 28.2 (9.4) 0.483
Severe LVSD, n (%) 126 (77.3) 84 (78.5) 42 (75.0) 0.612 98 (79.0) 28 (71.8) 0.347
Diabetes mellitus, n (%) 61 (36.3) 35 (31.3) 26 (46.4) 0.054 44 (34.1) 17 (43.6) 0.281
Hypertension, n (%) 98 (58.3) 63 (56.3) 35 (62.5) 0.439 75 (58.1) 23 (59.0) 0.926
Dyslipidemia, n (%) 90 (53.6) 53 (47.3) 37 (66.1) 0.022 66 (51.2) 24 (61.5) 0.255
Smoking, n (%) 84 (53.8) 53 (51.5) 31 (58.5) 0.404 63 (52.5) 21 (58.3) 0.538
Creatinine (mg/dL), median (IQR) 1.03 (0.64–2.70) 1.00 (0.68–1.79) 1.08 (0.67–2.39) 0.352 1.01 (0.66–2.05) 1.05 (0.73–1.48) 0.570
CAD, coronary artery disease; IQR, interquartile range; LVEF, left ventricular ejection fraction; LVSD, left ventricular systolic dysfunction; SD, standard deviation.
Table 2
Diagnostic yield, according to cardiovascular risk factors.
Signiﬁcant CAD Severe CAD
No Yes No Yes
Women No risk factors, n (%)a 14 (87.5) 2 (12.5) 14 (87.5) 2 (12.5)
Any risk factor, n (%)a 23 (69.7) 10 (30.3) 26 (78.8) 7 (21.2)
Men No risk factors, n (%)a 12 (85.7) 2 (14.3) 12 (85.7) 2 (14.3)
Any risk factor, n (%)a 63 (60.0) 42 (40.0) 77 (73.3) 28 (26.7)
CAD, coronary artery disease.
a Risk factors: diabetes mellitus, dyslipidemia, and smoking.
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Also, the extent of CAD is a signiﬁcant risk factor for cardiovascular out-
comes after MI is complicated by HF [9]. Additionally, patients with is-
chemic HF may beneﬁt from secondary preventive measures and
coronary revascularization [1,3,4].
According to the 2014 guidelines on myocardial revascularization,
CA continues to be the gold standard for the assessment of CAD severity
[2,3,9]. Some authors propose routine angiography in all patients with
HFrEF, because the presence of CAD is not uncommon among patients
with HF of unknown etiology [10]. In our population of 168 patients
withHFrEF andno angina, the prevalence of angiographically signiﬁcant
CAD was high (31%).
A clinical tool has been recently validated to help clinicians predict
the absence of severe CAD in patients with HFrEF and therefore elimi-
nate unnecessary CA. Independent predictors of severe CAD included
DM, electrocardiographic Q waves or left bundle branch block and at
least two nondiabetic risk factors. The presence of at least one of these
factors identiﬁed more than 95% of CAD cases and all of the patients
with severe disease [10]. This study, as ours, was limited, by having
included only those patients who had undergone angiography.
Our results corroborate previous observations, showing similar rates
of CAD in HFrEF patients without angina [4,10]. In our study, although
patients with signiﬁcant CAD had a higher prevalence of CVRF they
were not statistically signiﬁcantly different from patients without
CAD. We observed that both male groups (with or without CVRF) had
signiﬁcant CAD, which support the use of CA. Even 12.1% of women
without CVRF had signiﬁcant CAD.
Our study is a retrospective analysis with limitations and biases that
are inherent. Besides being a single center study, the patients weresubmitted to CA at the physicians' discretion. Also, known CAD was
based on the reported symptoms of typical angina and a history of
previous MI or coronary revascularization, which may have been
underreported. The relatively small sample size limits the generaliza-
tion of results and can underestimate the interactions between CVRF
and CAD. Additionally our population was relatively young, precluding
generalization of the observations, but one can speculate that with
increasing age the yield would be even higher, as CAD prevalence
increases with age.
In conclusion, our study shows that among HFrEF patients without
angina the prevalence of angiographically signiﬁcant CAD was high,
suggesting that the performance of routine CA should be considered in
HFrEF patients.
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